Pain management and stroke prevention in HHV-3-associated infection

Cover Page

Cite item

Full Text

Abstract

The modern information on the epidemiology, pathogenesis, clinical manifestations, diagnosis and pain management in HHV-3-associated neuro-infection is presented. The criteria for the phased diagnostics and approaches to the rational therapy for shingles and postherpetic neuralgia are presented. The conditions aimed at the prevention of pain due to the damage to peripheral nervous system and stroke due to HHV-3-associated vasculopathy are discussed.

About the authors

O. V. Kolokolov

Saratov State Medical University n.a. V.I. Razumovsky

Author for correspondence.
Email: kolokolov@inbox.ru

д-р мед. наук, доцент, зав. кафедрой неврологии им. К.Н. Третьякова

Russian Federation, Saratov

A. L. Bakulev

Saratov State Medical University n.a. V.I. Razumovsky

Email: kolokolov@inbox.ru

д-р мед. наук, профессор, зав. кафедрой дерматовенерологии и косметологии

Russian Federation, Saratov

A. A. Shuldyakov

Saratov State Medical University n.a. V.I. Razumovsky

Email: kolokolov@inbox.ru

д-р мед. наук, профессор, зав. кафедрой инфекционных болезней

Russian Federation, Saratov

N. S. Makarov

Saratov State Medical University n.a. V.I. Razumovsky

Email: kolokolov@inbox.ru

канд. мед. наук, доцент кафедры неврологии им. К.Н. Третьякова

Russian Federation, Saratov

I. V. Sitkali

Saratov State Medical University n.a. V.I. Razumovsky

Email: kolokolov@inbox.ru

ассистент кафедры неврологии им. К.Н. Третьякова

Russian Federation, Saratov

A. M. Kolokolova

Saratov State Medical University n.a. V.I. Razumovsky

Email: kolokolov@inbox.ru

канд. мед. наук, ассистент кафедры нервных болезней

Russian Federation, Saratov

S. S. Kravchenya

Saratov State Medical University n.a. V.I. Razumovsky

Email: kolokolov@inbox.ru

канд. мед. наук, зав. отделением клиники кожных и венерических болезней

Russian Federation, Saratov

References

  1. Dworkin RH, Johnson RW, Breuer J, et al. Recommendations for the management of herpes zoster. Clin Infect Dis. 2007;44(1):1-26. doi: 10.1086/510206.
  2. John AR, Canaday DH. Herpes zoster in the older adult. Infect Dis Clin North Am. 2017;31(4):811-826. doi: 10.1016/j.idc.2017.07.016.
  3. Schutzer-Weissmann J, Farquhar-Smith P. Post-herpetic neuralgia — a review of current management and future directions. Expert Opin Pharmacother. 2017;18(16):1739-1750. doi: 10.1080/14656566.2017.1392508.
  4. Дерматовенерология. Национальное руководство. / Под ред. Ю.К. Скрипкина, Ю.С. Бутова, О.Л. Иванова. — М.: ГЭОТАР-Медиа, 2011. — 1024 с. [Dermatovenereology. National leadership. Ed by YuK Skripkin, YuS Butov, OL Ivanov. Moscow: GEOTAR-Media; 2011. 1024 р. (In Russ).]
  5. Опоясывающий герпес. / Под ред. А.А. Кубановой. — М.: ДЭКС-ПреСС, 2010. — 24 с. [Herpes zoster. Ed by AA Kubanova. Moscow: DEKS-PreSS; 2010. 24 р. (In Russ).]
  6. Опоясывающий лишай [herpes zoster] у взрослых. Клинические рекомендации (Утв. Решением Пленума правления Национального научного общества инфекционистов 30 октября 2014 г.). — Национальное научное общество инфекционистов, 2014. 95 с. [Herpes zoster in adults. Clinical recommendations (Utv. Resheniem Plenuma pravleniya Natsional’nogo nauchnogo obshchestva infektsionistov 30 oktyabrya 2014 g.). Natsional’noe nauchnoe obshchestvo infektsionistov; 2014. 95 р. (In Russ).] Доступно по: http://nnoi.ru/uploads/files/protokoly/Herp_zoster.pdf. Ссылка активна на 19.01.2019.
  7. Таха Т.В. Опоясывающий герпес: клиника, диагностика, принципы терапии // РМЖ. — 2012. — Т.20. — №34. — С. 1644-1648. [Taha TV. Herpes zoster: clinic, diagnosis, principles of therapy. Russkij meditsinskij zhurnal. 2012;20(34):1644-1648. (In Russ).]
  8. Федеральные клинические рекомендации по ведению больных опоясывающим герпесом [интернет]. — М., 2015. [Federal clinical guidelines for managing patients with herpes zoster [Internet]. Moscow; 2015. (In Russ).] Доступно по: http://www.cnikvi.ru/docs/clinic_recs/bolezni-kozhi-i-pridatkov-kozhi/. Ссылка активна на 19.01.2019.
  9. Федеральные клинические рекомендации. Дерматовенерология [интернет]. — М., 2016. С. 305-314. [Federal clinical guidelines. Dermatovenereology [Internet]. Moscow; 2016. Рр. 305-314. (In Russ).] Доступно по: http://www.cnikvi.ru/docs/2335_maket_30.pdf. Ссылка активна на 19.01.2019.
  10. Mallick-Searle T, Snodgrass B, Brant JM. Postherpetic neuralgia: epidemiology, pathophysiology, and pain management pharmacology. J Multidiscip Healthc. 2016;9:447-454. doi: 10.2147/JMDH.S106340.
  11. Yawn BP, Gilden D. The global epidemiology of herpes zoster. Neurology. 2013;81(10):928-930. doi: 10.1212/WNL.0b013e3182a3516e.
  12. Львов Н.Д. Герпесвирусы человека — системная, интегративная, лимфопролиферативная иммуноонкопатология // РМЖ. — 2012. — Т.20. — №22.— С. 1133-1138. [Lvov ND. Human herpesviruses — systemic, integrative, lymphoproliferative immuno-oncopathology. Russkij meditsinskij zhurnal.2012;20(22):1133-1138. (In Russ).]
  13. Цукер М.Б. Поражения нервной системы, вызываемые вирусами группы герпеса // Клиническая медицина. — 1976. — Т.54. — №9. — С. 90-97. [Zucker MB. Defeats of the nervous system caused by viruses of the herpes group. Klinicheskaia meditsina. 1976;54(9):90-97. (In Russ).]
  14. Haug A, Mahalingam R, Cohrs RJ, et al. Recurrent polymorphonuclear pleocytosis with increased red blood cells caused by varicella zoster virus infection of the central nervous system: case report and review of the literature. J Neurol Sci. 2010;292(1-2):85-88. doi: 10.1016/j.jns.2010.01.019.
  15. Lee DH, Yoon TM, Lee JK, et al. Herpes zoster laryngitis accompanied by Ramsay Hunt syndrome. J Craniofac Surg. 2013;24(5):e496-498. doi: 10.1097/SCS.0b013e3182a12f95.
  16. McElveen WA. Postherpetic neuralgia. 2016. [updated 2018 Mar 06] Available from: https://emedicine.medscape.com/article/1143066-overview.
  17. Wang Z, Ye J, Han YH. Acute pancreatitis associated with herpes zoster: case report and literature review. World J Gastroenterol. 2014;20(47):18053-18056. doi: 10.3748/wjg.v20.i47.18053.
  18. Grahn A, Studahl M. Varicella-zoster virus infections of the central nervous system prognosis, diagnostics and treatment. J Infect. 2015;71(3):281-293. doi: 10.1016/j.jinf.2015.06.004.
  19. Wu PH, Chuang YS, Lin YT. Does Herpes Zoster increase the risk of stroke and myocardial infarction? A comprehensive review. J Clin Med. 2019;8(4). pii: E547. doi: 10.3390/jcm8040547.
  20. Chen VC, Wu SI, Huang KY, et al. Herpes Zoster and dementia: a nationwide population-based cohort study. J Clin Psychiatry. 2018;79(1). pii: 16m11312. doi: 10.4088/JCP.16m11312.
  21. Loncar Z, Mestrović AH, Bilić M, et al. Quality of pain in herpes zoster patients. Coll Antropol. 2013;37(2):527-530.
  22. Nalamachu S, Morley-Forster P. Diagnosing and managing post-herpetic neuralgia. Drugs Aging. 2012;29(11):863-869. doi: 10.1007/s40266-012-0014-3.
  23. Tontodonati M, Ursini T, Polilli E, et al Post-herpetic neuralgia. Int J Gen Med. 2012;5:861-871. doi: 10.2147/IJGM.S10371.
  24. Coplan PM, Schmader K, Nikas A. Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory. J Pain. 2004;5(6):344-356. doi: 10.1016/j.jpain.2004.06.001.
  25. Werner RN, Nikkels AF, Marinoviс B, et al. European consensus-based (S2k) Guideline on the management of herpes zoster — guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 1: Diagnosis. J Eur Acad Dermatol Venereol. 2017;31(1):20-29. doi: 10.1111/jdv.13957.
  26. Wang L, Zhu L, Zhu H. Efficacy of varicella (VZV) vaccination: an update for the clinician. Ther Adv Vaccines. 2016;4(1-2):20-31. doi: 10.1177/2051013616655980.
  27. Arnold N, Messaoudi I. Herpes zoster and the search for an effective vaccine. Clin Exp Immunol. 2017;187(1):82-92. doi: 10.1111/cei.12809.
  28. Langan SM, Smeeth L, Margolis DJ, Thomas SL. Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study. PLoS Med. 2013;10(4):e1001420. doi: 10.1371/journal.pmed.1001420.
  29. Chen N, Li Q, Yang J, et al. Antiviral treatment for preventing post-herpetic neuralgia. Cochrane Database Syst Rev. 2014;(2):CD006866. doi: 10.1002/14651858.CD006866.pub3.
  30. Mueller NH, Gilden DH, Cohrs RJ, et al. Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency. Neurol Clin. 2008;26(3):675-697, viii. doi: 10.1016/j.ncl.2008.03.011.
  31. IASP. Treating herpes zoster and post-herpetic neuralgia. The International Association for the Study of Pain, 2015. Available from: https://www.iasp-pain.org.
  32. Werner RN, Nikkels AF, Marinoviс B, et al. European consensus-based (S2k) Guideline on the management of herpes zoster — guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment. J Eur Acad Dermatol Venereol. 2017;31(1):20-29. doi: 10.1111/jdv.13957.
  33. Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162-173. doi: 10.1016/S1474-4422(14)70251-0.
  34. Gaskell H, Derry S, Stannard C, Moore RA. Oxycodone for neuropathic pain in adults. Cochrane Database Syst Rev. 2016;7:CD010692. doi: 10.1002/14651858.CD010692.pub3.
  35. Johnson RW, Rice AS. Clinical practice. Postherpetic neuralgia. N Engl J Med. 2014;371(16):1526-1533. doi: 10.1056/NEJMcp1403062.
  36. Chaparro LE, Wiffen PJ, Moore RA, Gilron I. Combination pharmacotherapy for the treatment of neuropathic pain in adults. Cochrane Database Syst Rev. 2012;(7):CD008943. doi: 10.1002/14651858.CD008943.pub2.
  37. Crosbie B, Lucey S, Tilson L, et al. Acute herpes zoster and post herpetic neuralgia in primary care: a study of diagnosis, treatment and cost. Eur J Clin Microbiol Infect Dis. 2018;37(4):627-631. doi: 10.1007/s10096-017-3153-y.

Copyright (c) 2019 Kolokolov O.V., Bakulev A.L., Shuldyakov A.A., Makarov N.S., Sitkali I.V., Kolokolova A.M., Kravchenya S.S.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies